Cargando…
Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402118/ https://www.ncbi.nlm.nih.gov/pubmed/30836977 http://dx.doi.org/10.1186/s13045-019-0715-8 |
| _version_ | 1783400323608477696 |
|---|---|
| author | Yan, Chen-Hua Wang, Yu Wang, Jing-Zhi Chen, Yu-Hong Chen, Yao Wang, Feng-rong Sun, Yu-Qian Mo, Xiao-Dong Han, Wei Chen, Huan Zhang, Xiao-hui Xu, Lan-Ping Liu, Kai-Yan Huang, Xiao-Jun |
| author_facet | Yan, Chen-Hua Wang, Yu Wang, Jing-Zhi Chen, Yu-Hong Chen, Yao Wang, Feng-rong Sun, Yu-Qian Mo, Xiao-Dong Han, Wei Chen, Huan Zhang, Xiao-hui Xu, Lan-Ping Liu, Kai-Yan Huang, Xiao-Jun |
| author_sort | Yan, Chen-Hua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6402118 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64021182019-03-14 Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant Yan, Chen-Hua Wang, Yu Wang, Jing-Zhi Chen, Yu-Hong Chen, Yao Wang, Feng-rong Sun, Yu-Qian Mo, Xiao-Dong Han, Wei Chen, Huan Zhang, Xiao-hui Xu, Lan-Ping Liu, Kai-Yan Huang, Xiao-Jun J Hematol Oncol Correction BioMed Central 2019-03-05 /pmc/articles/PMC6402118/ /pubmed/30836977 http://dx.doi.org/10.1186/s13045-019-0715-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Yan, Chen-Hua Wang, Yu Wang, Jing-Zhi Chen, Yu-Hong Chen, Yao Wang, Feng-rong Sun, Yu-Qian Mo, Xiao-Dong Han, Wei Chen, Huan Zhang, Xiao-hui Xu, Lan-Ping Liu, Kai-Yan Huang, Xiao-Jun Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title | Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title_full | Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title_fullStr | Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title_full_unstemmed | Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title_short | Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| title_sort | correction to: minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402118/ https://www.ncbi.nlm.nih.gov/pubmed/30836977 http://dx.doi.org/10.1186/s13045-019-0715-8 |
| work_keys_str_mv | AT yanchenhua correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT wangyu correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT wangjingzhi correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT chenyuhong correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT chenyao correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT wangfengrong correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT sunyuqian correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT moxiaodong correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT hanwei correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT chenhuan correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT zhangxiaohui correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT xulanping correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT liukaiyan correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant AT huangxiaojun correctiontominimalresidualdiseaseandgraftvshostdiseaseguidedmultipleconsolidationchemotherapyanddonorlymphocyteinfusionpreventsecondacuteleukemiarelapseafterallotransplant |